Jessica Gerald Young, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Causality | 13 | 2023 | 1247 | 1.770 |
Why?
|
Models, Statistical | 13 | 2023 | 5088 | 1.230 |
Why?
|
Health Systems Plans | 1 | 2019 | 20 | 0.630 |
Why?
|
Likelihood Functions | 2 | 2021 | 993 | 0.630 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2020 | 161 | 0.620 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 168 | 0.610 |
Why?
|
Peptic Ulcer | 1 | 2020 | 214 | 0.610 |
Why?
|
Fertility | 1 | 2021 | 770 | 0.530 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2020 | 2538 | 0.510 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 388 | 0.490 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 551 | 0.460 |
Why?
|
Research Design | 5 | 2023 | 6204 | 0.460 |
Why?
|
Clinical Protocols | 1 | 2019 | 1435 | 0.430 |
Why?
|
Algorithms | 5 | 2023 | 14064 | 0.420 |
Why?
|
Drug Utilization | 1 | 2019 | 1187 | 0.410 |
Why?
|
Feeding Behavior | 3 | 2022 | 3209 | 0.390 |
Why?
|
Regression Analysis | 4 | 2020 | 6321 | 0.370 |
Why?
|
Critical Illness | 2 | 2023 | 2749 | 0.360 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 949 | 0.360 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2726 | 0.330 |
Why?
|
Survival Analysis | 4 | 2023 | 10086 | 0.300 |
Why?
|
Body Mass Index | 5 | 2021 | 13042 | 0.300 |
Why?
|
Ambulatory Care | 1 | 2019 | 2778 | 0.290 |
Why?
|
Probability | 3 | 2023 | 2474 | 0.290 |
Why?
|
Premature Birth | 1 | 2019 | 1830 | 0.280 |
Why?
|
Data Interpretation, Statistical | 4 | 2022 | 2688 | 0.270 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12529 | 0.270 |
Why?
|
Dioxins | 1 | 2007 | 91 | 0.270 |
Why?
|
Anti-Bacterial Agents | 3 | 2019 | 7473 | 0.260 |
Why?
|
Environmental Exposure | 4 | 2023 | 4544 | 0.250 |
Why?
|
Confidentiality | 2 | 2019 | 607 | 0.240 |
Why?
|
Reflex, Abnormal | 1 | 2005 | 83 | 0.240 |
Why?
|
Diet | 2 | 2022 | 8087 | 0.230 |
Why?
|
Computer Simulation | 7 | 2023 | 6251 | 0.230 |
Why?
|
Environmental Pollutants | 2 | 2023 | 1294 | 0.220 |
Why?
|
Risk Assessment | 2 | 2020 | 24275 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10380 | 0.210 |
Why?
|
Leiomyoma | 1 | 2007 | 644 | 0.200 |
Why?
|
Pesticides | 1 | 2005 | 297 | 0.200 |
Why?
|
Models, Structural | 1 | 2022 | 338 | 0.190 |
Why?
|
Alkanesulfonic Acids | 1 | 2023 | 199 | 0.180 |
Why?
|
Stochastic Processes | 1 | 2021 | 358 | 0.170 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2020 | 146 | 0.170 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2023 | 279 | 0.160 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2022 | 352 | 0.160 |
Why?
|
Child, Preschool | 6 | 2022 | 42510 | 0.160 |
Why?
|
Organizational Affiliation | 1 | 2019 | 34 | 0.160 |
Why?
|
Satiation | 1 | 2019 | 84 | 0.150 |
Why?
|
Pregnancy | 7 | 2023 | 30230 | 0.150 |
Why?
|
Appetite Regulation | 1 | 2019 | 84 | 0.150 |
Why?
|
Poisson Distribution | 1 | 2019 | 507 | 0.150 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 418 | 0.150 |
Why?
|
Selection Bias | 1 | 2020 | 359 | 0.150 |
Why?
|
Phthalic Acids | 1 | 2023 | 485 | 0.150 |
Why?
|
Fluorocarbons | 1 | 2023 | 499 | 0.150 |
Why?
|
Boston | 2 | 2021 | 9334 | 0.140 |
Why?
|
Humans | 39 | 2024 | 765926 | 0.140 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15645 | 0.140 |
Why?
|
Computer Security | 1 | 2019 | 261 | 0.140 |
Why?
|
Privacy | 1 | 2019 | 232 | 0.140 |
Why?
|
Epoetin Alfa | 1 | 2017 | 78 | 0.140 |
Why?
|
Breast Feeding | 2 | 2023 | 1363 | 0.140 |
Why?
|
Maternal Age | 1 | 2019 | 804 | 0.130 |
Why?
|
Risk Adjustment | 1 | 2019 | 596 | 0.130 |
Why?
|
Body Composition | 3 | 2023 | 2441 | 0.130 |
Why?
|
Hematocrit | 1 | 2017 | 622 | 0.130 |
Why?
|
Female | 22 | 2023 | 396141 | 0.120 |
Why?
|
Adolescent | 8 | 2023 | 88811 | 0.120 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2015 | 1899 | 0.120 |
Why?
|
Glucose Intolerance | 1 | 2019 | 578 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1729 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2020 | 1404 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2022 | 1919 | 0.100 |
Why?
|
Biostatistics | 1 | 2013 | 162 | 0.100 |
Why?
|
Male | 17 | 2024 | 363815 | 0.100 |
Why?
|
Smoking Cessation | 1 | 2023 | 2084 | 0.090 |
Why?
|
Infant | 4 | 2022 | 36426 | 0.090 |
Why?
|
Mothers | 2 | 2019 | 2206 | 0.090 |
Why?
|
Information Dissemination | 1 | 2019 | 1142 | 0.090 |
Why?
|
Electronic Health Records | 2 | 2019 | 4863 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3616 | 0.090 |
Why?
|
Coronary Disease | 2 | 2016 | 5919 | 0.090 |
Why?
|
Comparative Effectiveness Research | 1 | 2015 | 713 | 0.080 |
Why?
|
Fishes | 1 | 2013 | 607 | 0.080 |
Why?
|
Bone Density | 2 | 2023 | 3491 | 0.080 |
Why?
|
Markov Chains | 1 | 2013 | 971 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2022 | 3560 | 0.080 |
Why?
|
Incidence | 3 | 2024 | 21513 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6503 | 0.080 |
Why?
|
Diabetes, Gestational | 1 | 2019 | 1263 | 0.080 |
Why?
|
Cohort Studies | 6 | 2023 | 41680 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2741 | 0.080 |
Why?
|
Terminal Care | 1 | 2020 | 1769 | 0.080 |
Why?
|
Child | 6 | 2023 | 80568 | 0.080 |
Why?
|
Statistical Distributions | 1 | 2007 | 60 | 0.070 |
Why?
|
Risk Factors | 8 | 2022 | 74850 | 0.070 |
Why?
|
Anemia | 1 | 2017 | 1514 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9656 | 0.070 |
Why?
|
Logistic Models | 2 | 2020 | 13273 | 0.070 |
Why?
|
HIV Infections | 3 | 2024 | 17531 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3799 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 2184 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2019 | 26380 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2017 | 14745 | 0.060 |
Why?
|
Obesity | 2 | 2019 | 13082 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6202 | 0.060 |
Why?
|
HIV | 1 | 2012 | 1587 | 0.060 |
Why?
|
Weight Loss | 1 | 2016 | 2710 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9443 | 0.060 |
Why?
|
Biometry | 1 | 2007 | 571 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2012 | 2204 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6268 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 314 | 0.050 |
Why?
|
Carbamazepine | 1 | 2022 | 224 | 0.050 |
Why?
|
Adult | 9 | 2023 | 223088 | 0.040 |
Why?
|
Lactation | 1 | 2023 | 391 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 12235 | 0.040 |
Why?
|
Valproic Acid | 1 | 2022 | 444 | 0.040 |
Why?
|
Goals | 1 | 2023 | 717 | 0.040 |
Why?
|
Waist Circumference | 1 | 2021 | 934 | 0.040 |
Why?
|
Smoking | 3 | 2023 | 9082 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 2 | 2015 | 2586 | 0.040 |
Why?
|
Overweight | 2 | 2021 | 2444 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2023 | 81537 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2021 | 702 | 0.030 |
Why?
|
Death | 1 | 2020 | 686 | 0.030 |
Why?
|
Food Supply | 1 | 2021 | 544 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2019 | 1180 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2024 | 1342 | 0.030 |
Why?
|
Aged | 4 | 2023 | 171163 | 0.030 |
Why?
|
Propensity Score | 1 | 2023 | 1971 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2023 | 1359 | 0.030 |
Why?
|
Viral Load | 2 | 2015 | 3385 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2024 | 1786 | 0.030 |
Why?
|
Middle Aged | 5 | 2022 | 223016 | 0.030 |
Why?
|
Anthropometry | 1 | 2018 | 1339 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2018 | 1707 | 0.030 |
Why?
|
Developed Countries | 1 | 2015 | 452 | 0.020 |
Why?
|
Policy | 1 | 2015 | 512 | 0.020 |
Why?
|
Critical Care | 1 | 2023 | 2713 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12822 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3886 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2350 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5873 | 0.020 |
Why?
|
Young Adult | 3 | 2022 | 59857 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26282 | 0.020 |
Why?
|
Adiposity | 1 | 2018 | 1891 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3430 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5300 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1238 | 0.020 |
Why?
|
United States | 3 | 2015 | 72909 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1791 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2013 | 752 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2018 | 3314 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2132 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1539 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54807 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12059 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10727 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2504 | 0.010 |
Why?
|
Blood Glucose | 1 | 2019 | 6422 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8060 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18382 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8223 | 0.010 |
Why?
|
Life Style | 1 | 2013 | 3928 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4041 | 0.010 |
Why?
|
Stroke | 1 | 2022 | 9739 | 0.010 |
Why?
|
Mass Screening | 1 | 2015 | 5449 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10575 | 0.010 |
Why?
|
HIV-1 | 1 | 2015 | 6945 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6544 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40097 | 0.010 |
Why?
|
Heart Failure | 1 | 2017 | 11837 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39228 | 0.010 |
Why?
|
Animals | 1 | 2013 | 168735 | 0.000 |
Why?
|